Literature DB >> 27751556

The epidemiology of Parkinson's disease: risk factors and prevention.

Alberto Ascherio1, Michael A Schwarzschild2.   

Abstract

Since 2006, several longitudinal studies have assessed environmental or behavioural factors that seem to modify the risk of developing Parkinson's disease. Increased risk of Parkinson's disease has been associated with exposure to pesticides, consumption of dairy products, history of melanoma, and traumatic brain injury, whereas a reduced risk has been reported in association with smoking, caffeine consumption, higher serum urate concentrations, physical activity, and use of ibuprofen and other common medications. Randomised trials are investigating the possibility that some of the negative risk factors might be neuroprotective and thus beneficial in individuals with early Parkinson's disease, particularly with respect to smoking (nicotine), caffeine, and urate. In the future, it might be possible to identify Parkinson's disease in its prodromal phase and to promote neuroprotective interventions before the onset of motor symptoms. At this time, however, the only intervention that seems justifiable for the primary prevention of Parkinson's disease is the promotion of physical activity, which is likely to be beneficial for the prevention of several chronic diseases.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2016        PMID: 27751556     DOI: 10.1016/S1474-4422(16)30230-7

Source DB:  PubMed          Journal:  Lancet Neurol        ISSN: 1474-4422            Impact factor:   44.182


  385 in total

1.  Small molecule-driven NLRP3 inflammation inhibition via interplay between ubiquitination and autophagy: implications for Parkinson disease.

Authors:  Xiaojuan Han; Sifan Sun; Yiming Sun; Qiqi Song; Jialei Zhu; Nanshan Song; Miaomiao Chen; Ting Sun; Meiling Xia; Jianhua Ding; Ming Lu; Honghong Yao; Gang Hu
Journal:  Autophagy       Date:  2019-04-09       Impact factor: 16.016

2.  Interaction between caffeine and polymorphisms of glutamate ionotropic receptor NMDA type subunit 2A (GRIN2A) and cytochrome P450 1A2 (CYP1A2) on Parkinson's disease risk.

Authors:  Iris Y Kim; Éilis J O'Reilly; Katherine C Hughes; Xiang Gao; Michael A Schwarzschild; Marjorie L McCullough; Marian T Hannan; Rebecca A Betensky; Alberto Ascherio
Journal:  Mov Disord       Date:  2018-01-10       Impact factor: 10.338

3.  Study on Mechanism of Ginkgo biloba L. Leaves for the Treatment of Neurodegenerative Diseases Based on Network Pharmacology.

Authors:  Jing Wang; Xialin Chen; Weirong Bai; Zhenzhong Wang; Wei Xiao; Jingbo Zhu
Journal:  Neurochem Res       Date:  2021-05-14       Impact factor: 3.996

4.  The Emerging Role of Biomarkers in Adaptive Modulation of Clinical Brain Stimulation.

Authors:  Kimberly B Hoang; Dennis A Turner
Journal:  Neurosurgery       Date:  2019-09-01       Impact factor: 4.654

5.  mHealth and wearable technology should replace motor diaries to track motor fluctuations in Parkinson's disease.

Authors:  M Kelley Erb; Daniel R Karlin; Bryan K Ho; Kevin C Thomas; Federico Parisi; Gloria P Vergara-Diaz; Jean-Francois Daneault; Paul W Wacnik; Hao Zhang; Tairmae Kangarloo; Charmaine Demanuele; Chris R Brooks; Craig N Detheridge; Nina Shaafi Kabiri; Jaspreet S Bhangu; Paolo Bonato
Journal:  NPJ Digit Med       Date:  2020-01-17

6.  No clear support for a role for vitamin D in Parkinson's disease: A Mendelian randomization study.

Authors:  Susanna C Larsson; Andrew B Singleton; Mike A Nalls; J Brent Richards
Journal:  Mov Disord       Date:  2017-06-08       Impact factor: 10.338

7.  FOXRED1 silencing in mice: a possible animal model for Leigh syndrome.

Authors:  Mohamed Salama; Sara El-Desouky; Aziza Alsayed; Mahmoud El-Hussiny; Abdelrahman Moustafa; Yasmeen Taalab; Wael Mohamed
Journal:  Metab Brain Dis       Date:  2018-11-03       Impact factor: 3.584

8.  The relationship between Parkinson's disease symptoms and caregiver quality of life.

Authors:  Richard S Henry; Sarah K Lageman; Paul B Perrin
Journal:  Rehabil Psychol       Date:  2020-02-17

9.  Parkinson's Disease Master Regulators on Substantia Nigra and Frontal Cortex and Their Use for Drug Repositioning.

Authors:  D M Vargas; M A De Bastiani; R B Parsons; F Klamt
Journal:  Mol Neurobiol       Date:  2020-11-19       Impact factor: 5.590

Review 10.  Functional nanoarrays for investigating stem cell fate and function.

Authors:  Jin-Ho Lee; Jeffrey Luo; Hye Kyu Choi; Sy-Tsong Dean Chueng; Ki-Bum Lee; Jeong-Woo Choi
Journal:  Nanoscale       Date:  2020-02-24       Impact factor: 7.790

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.